• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• The Hindu ePaper
• Business Line
• Business Line ePaper
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Hyderabad, May 7

Aurobindo Pharma Ltd has received the US FDA approval for its Zolpidem tablets in strengths 5mg and 10mg. Zolpidem belongs to the class of imidazopyridines (medicines acting on central nervous system). It is the generic version of the brand Ambien manufactured and sold by Sanofi Aventis. It is used in short-term treatment of insomnia. Zolpidem has a market share of around $2.1 billion in the US, according to a release.

More Stories on : Regulatory Bodies & Rulings | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Tata Sky objects to Turner's plea

Copyright © 2007, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line